MedPath

Pimozide

Pimozide Tablets, USP

Approved
Approval ID

70b079e2-a1f7-4a93-8685-d60a4d7c1280

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 25, 2017

Manufacturers
FDA

Par Pharmaceutical, Inc.

DUNS: 092733690

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pimozide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49884-348
Application NumberANDA204521
Product Classification
M
Marketing Category
C73584
G
Generic Name
Pimozide
Product Specifications
Route of AdministrationORAL
Effective DateNovember 25, 2017
FDA Product Classification

INGREDIENTS (5)

ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
PIMOZIDEActive
Quantity: 2 mg in 1 1
Code: 1HIZ4DL86F
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

Pimozide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49884-347
Application NumberANDA204521
Product Classification
M
Marketing Category
C73584
G
Generic Name
Pimozide
Product Specifications
Route of AdministrationORAL
Effective DateNovember 25, 2017
FDA Product Classification

INGREDIENTS (5)

PIMOZIDEActive
Quantity: 1 mg in 1 1
Code: 1HIZ4DL86F
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pimozide - FDA Drug Approval Details